{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P11362",
      "entity_text" : "FGFR1",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:Q9NSA1",
      "entity_text" : "FGF21",
      "entity_type" : "protein"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "To determine whether FGF21 induced FGFR1 and ERK1/2 activation is responsible for its cardioprotective effect, H9c2 cells were treated with FGFR1 inhibitor, PD166866 or ERK1/2 inhibitor, PD98059 before being transfected with pcDNA4-FGF21 and the addition of TM.",
  "reading_complete" : "2020-08-03T17:19:44Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T17:18:22Z",
  "trigger" : "induced",
  "evidence" : [ "FGF21-induced FGFR1" ],
  "pmc_id" : "5627875",
  "score" : 0
}